Recent studies in a murine cancer model and chronic LCMV infection demonstrated that TCF1+ precursor exhausted CD8+ T cells comprise a specific fraction of CD8+ T cells that proliferate after PD-1 blockade therapy to form a large pool of short-lived cytotoxic effectors (25). Here, CD8A is linked to cancer.